The National Institutes of Health will host a virtual learning session entitled 'Biomedical Informatics and Data Sciences in Africa' on 30 September 2020 as part of the DS-I Africa Virtual Forum series. This session will address emerging opportunities and challenges in the application of Data Science and Informatics technologies in various biomedical domains. It will

The National Institutes of Health will host a virtual learning session entitled 'Innovative Approaches to Improve Maternal and Child Health' on 7 October 2020 as part of the DS-I Africa Virtual Forum series. Maternal and child health outcomes in Africa still lag behind the rest of the world despite prioritization as a topic of focus

The National Institutes of Health will host a virtual learning session entitled ‘Using Data Science to Fight COVID-19' on 14 October 2020 as part of the DS-I Africa Virtual Forum series. Moderator: Stefan Jaeger, National Library of Medicine, National Institutes of Health Panelists: Agnes Kiragga, Ph.D., Head of Statistics and Data Management Unit and Senior

The National Institutes of Health will host a virtual learning session entitled ‘Innovations in Health Metrics Sciences: Measuring, Mapping, and Monitoring Morbidity and Mortality at the Regional, National, and Local Levels in Africa' on 21 October 2020 as part of the DS-I Africa Virtual Forum series. This session will highlight the emerging field of health

On October 22, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session, to discuss, in general, the development, authorization and/or licensure of vaccines to prevent COVID-19. No specific application will be discussed at this meeting. FDA intends to make background material available to

The National Virtual Biotechnology Laboratory Symposium will be held Oct. 28, 2020. This online event will highlight the impact the U.S. Department of Energy's (DOE) National Virtual Biotechnology Laboratory has had utilizing the unique capabilities of the DOE to tackle the science and technology challenges associated with COVID-19, and to discuss areas in which the